Upstate Medical University

ELabNYC Research and Development Masterclass, New York, New York

This one-day course features pharma sharing their approach to R&D processes to inform and assist not only attendees own R&D efforts but also the timing and manner of their outreach to investors and pharma. Learn how to plan go-no go decision points that align with investment.

​You may participate in-person or virtually. Use our discount code for your ticket! Our discount code 1KEQL1 gives you 20% off. This code is valid through February 8, 2024.

​More Info: Research and Development Masterclass · Luma

Topics discussed will include:

  • ​Assessment of competition and risk

  • ​Importance of a Target Product Profile (TPP)

  • ​Role of market assessment

  • ​Meaningful milestones in an R&D program

  • ​Reducing clinical risk in the preclinical program

  • ​GO/NO GO decision points

  • ​When external R&D becomes important


​Agenda

8:30AM-8:45AM Welcome, Introductions of participants 

9:00AM-9:30AM Pre-clinical research post COVID (AI, modeling tools, spatial biology) 

9:30AM-10:00AM Pharma decision metrics for R spend 

10:00AM-10:30AM  Meaning milestones in an R&D program 

10:30AM-10:45AM Break 

10:45AM-11:15AM  R&D Milestone exercise 

11:15AM-12:00PM  R&D investment by stage 

12:00PM-1:00PM Lunch 

1:00PM-1:30PM  Clinical risk management in pre-clinical program 

1:30PM-2:00PM  Role of GO/NO GO Decision points by R&D stage 

2:00PM-2:30PM  Exercise mapping participant clinical risk management strategy 

2:30PM-2:45PM  Break 

2:45PM-3:15PM When does external R&D become important 

3:15PM-3:45PM How does pharma access external R&D 

3:45PM-4:30PM Trends in business development 

4:30PM-5:00PM Wrap up

5:00PM-7:00PM Reception